Alkermes Sees Payer Savings Opportunity With Aristada Approval
This article was originally published in The Pink Sheet Daily
Executive Summary
Long-acting injectable aripiprazole lauroxil cleared six weeks late, but Alkermes is happy with label's flexibility on dosing, saying product will be differentiated from Abilify Maintena.